Azurion Lung Edition is supports precision diagnosis and minimally invasive therapy in one room.
Global imaging provider Royal Philips announced the launch of its Azurion Lung Edition Monday. This advanced 3D imaging and navigation system combines CT and X-ray to support image-guided lung procedures.
By bringing together CT-like 3D images acquired at the tableside (Cone Bean CT) and live X-ray guidance, the system works specifically for bronchoscopy procedures. According to company officials it allows clinicians to perform both minimally invasive endobronchial biopsies, as well as lesion ablation, in the same procedure, potentially accelerating diagnosis and treatment.
Azurion Lung Suite. Courtesy: Royal Philips
Currently, worldwide, approximately 1.7 million people die from lung cancer – 60 percent of whom have been diagnosed at a late state where a surgical cure is unlikely. However, recent developments with earlier diagnosis and faster therapies – of which Cone Beam CT is considered the gold standard for treatment in one room – are showing promise in treating these patients.
Azurion Lung Suite Ablation. Courtesy: Royal Philips
“This is a very exciting time in the world of interventional pulmonology and advanced bronchoscopy,” said Michal Pritchett, M.D., director of the Chest Center of the Carolinas, FirstHealth Moore Regional Hospital, Pinehurst Medical Clinic. “One of the things that we’re particularly excited about is being able to diagnose patients, stage their cancer and treat them, all in a single procedure. As a diagnostic bronchoscopist, it’s exciting and rewarding to be able not only to diagnose patients, but to go on to treat them, as well.”
And, by combining Cone Beam CT with other technologies, such as robotics, said Gustavo Cumbo-Nacheli, M.D., director of bronchoscopy and interventional pulmonology at Spectrum Health in Grand Rapids, Mich., clinicians will be able to push beyond biopsy into greater treatment for the patient.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.